Healthcare was Steris’s largest segment in fiscal 2026, bringing in $1.50B of $3.22B (46%).
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|
| Healthcare | $1.05B | $1.27B | $1.45B | $1.50B | |||
| Ast | $914.43M | $939.50M | $1.01B | $1.14B | |||
| Applied Sterilization Technologies | — | — | — | — | |||
| Healthcare Products | — | — | — | — | |||
| Healthcare Specialty Services | — | — | — | — | |||
| Life Sciences | $536.70M | $251.60M | $286.70M | $588.80M | |||
| Life Science | — | — | — | — | |||
| Total | $2.50B | $2.46B | $2.74B | $3.22B |
Steris brought in $3.22B from its three segments in fiscal 2026, the year ended March 31, 2026. That is less than the $5.94B it reports by geography, so these segments do not cover all of its revenue. Healthcare was the largest at $1.50B (46.4%), ahead of Ast at $1.14B (35.3%) and Life Sciences at $588.80M (18.3%).
Compared with fiscal 2025, Life Sciences grew fastest, up 105.4% to $588.80M. Every segment above 2% of revenue grew.
Service was Steris’s largest product and service line in fiscal 2026, bringing in $1.62B of $4.21B (38%).
| Product and Service | FY 2017 | FY 2017 | FY 2017 | FY 2018 | FY 2018 | FY 2018 | FY 2018 | FY 2019 | FY 2019 | FY 2019 | FY 2019 | FY 2020 | FY 2020 | FY 2020 | FY 2020 | FY 2021 | FY 2021 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $1.14B | $1.27B | $1.45B | $1.62B | ||||||||||||||||||||
| Service Revenues | — | — | — | — | ||||||||||||||||||||
| Capital Equipment | $896.59M | $1.09B | $1.04B | $1.10B | ||||||||||||||||||||
| Capital Equipment Revenues | — | — | — | — | ||||||||||||||||||||
| Consumables | $241.11M | $1.25B | $1.40B | $1.50B | ||||||||||||||||||||
| Consumable Revenues | — | — | — | — | ||||||||||||||||||||
| Product | $2.36B | — | — | — | ||||||||||||||||||||
| Total | $4.64B | $3.61B | $3.88B | $4.21B |
Steris brought in $4.21B from its three product and service lines in fiscal 2026, the year ended March 31, 2026. That is less than the $5.94B it reports by geography, so these lines do not cover all of its revenue. Service was the largest at $1.62B (38.4%), ahead of Consumables at $1.50B (35.6%) and Capital Equipment at $1.10B (26.0%).
Compared with fiscal 2025, Service grew fastest, up 11.8% to $1.62B. Every line above 2% of revenue grew.
Steris stopped reporting Product as a separate line after fiscal 2023, when it brought in $2.36B.
United States was Steris’s largest region in fiscal 2026, bringing in $4.33B of $5.94B (73%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|
| United States | $3.75B | $4.01B | $4.33B | |||||
| Other Foreign Locations | $1.30B | $1.34B | $1.49B | |||||
| Ireland | $82.70M | $107.30M | $108.50M | |||||
| United Kingdom | — | — | — | |||||
| Total | $5.14B | $5.46B | $5.94B |
Steris brought in $5.94B from its three regions in fiscal 2026, the year ended March 31, 2026. That was up 8.7% from $5.46B in fiscal 2025. United States was the largest at $4.33B (73.0%), ahead of Other Foreign Locations at $1.49B (25.2%) and Ireland at $108.50M (1.8%).
Compared with fiscal 2025, Other Foreign Locations grew 11.1% to $1.49B and United States grew 8.1% to $4.33B. From fiscal 2024 to 2026, combined revenue from these regions grew from $5.14B to $5.94B, a compound annual growth rate of 7.5%. United States' share held steady at about 73.0%.
Steris (STE) reports its revenue by segment, by product and service and by geography. In fiscal 2026, Healthcare was its largest segment, bringing in $1.50B (46.4% of the total), followed by Ast at $1.14B (35.3%).
Healthcare was Steris' largest segment in fiscal 2026, bringing in $1.50B, or 46.4% of the $3.22B total across its three segments.
Service was Steris' largest product and service line in fiscal 2026, bringing in $1.62B, or 38.4% of the $4.21B total across its three product and service lines.
United States was Steris' largest region in fiscal 2026, bringing in $4.33B, or 73.0% of the $5.94B total across its three regions.
Among Steris' segments that make up at least 2% of revenue, Life Sciences grew fastest in fiscal 2026, up 105.4% from $286.70M to $588.80M.
Every figure comes from Steris' annual financial filings, as reported. Each line keeps the name Steris gives it, and years follow its fiscal calendar.
Steris' revenue by segment goes back to fiscal 2017, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.